The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aclaris Therapeutics Inc | COM | 00461U105 | 9,693,211 | 1,832,365 | SH | SOLE | 1,832,365 | 0 | 0 | ||
| Atyr Pharma Inc | COM NEW | 002120202 | 1,067,178 | 1,788,167 | SH | SOLE | 1,788,167 | 0 | 0 | ||
| Compass Pathways Plc | SPONSORED ADS | 20451W101 | 11,598,642 | 819,692 | SH | SOLE | 819,692 | 0 | 0 | ||
| Cyclerion Therapeutics Inc | COM | 23255M204 | 5,598,077 | 1,651,350 | SH | SOLE | 1,651,350 | 0 | 0 | ||
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 3,615,390 | 139,000 | SH | SOLE | 139,000 | 0 | 0 | ||
| Gossamer Bio Inc | COM | 38341P102 | 1,835,185 | 11,149,363 | SH | SOLE | 11,149,363 | 0 | 0 | ||
| Inflarx Nv | COM | N44821101 | 6,491,003 | 2,897,769 | SH | SOLE | 2,897,769 | 0 | 0 | ||
| Inhibikase Therapeutics Inc | COM NEW | 45719W205 | 7,758,437 | 3,821,890 | SH | SOLE | 3,821,890 | 0 | 0 | ||
| Instil Bio Inc | COM NEW | 45783C200 | 765,924 | 99,600 | SH | SOLE | 99,600 | 0 | 0 | ||
| Karyopharm Therapeutics Inc | COM NEW | 48576U205 | 6,698,742 | 685,644 | SH | SOLE | 685,644 | 0 | 0 | ||
| LeonaBio Inc | COM | 04746L203 | 3,618,112 | 393,701 | SH | SOLE | 393,701 | 0 | 0 | ||
| Milestone Pharmaceuticals Inc | COM | 59935V107 | 1,700,778 | 1,269,237 | SH | SOLE | 1,269,237 | 0 | 0 | ||
| MoonLake Immunotherapeutics | CLASS A ORD | 61559X104 | 3,421,541 | 175,734 | SH | SOLE | 175,734 | 0 | 0 | ||
| Nuvectis Pharma Inc | COM | 67080T108 | 1,839,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| Pharvaris NV | COM | N69605108 | 6,873,536 | 198,772 | SH | SOLE | 198,772 | 0 | 0 | ||
| Septerna Inc | COM | 81734D104 | 6,515,279 | 194,544 | SH | SOLE | 194,544 | 0 | 0 | ||
| Sionna Therapeutics Inc | COM | 829401108 | 8,669,197 | 197,072 | SH | SOLE | 197,072 | 0 | 0 | ||
| Surrozen Inc | COM NEW | 86889P208 | 9,995,369 | 385,178 | SH | SOLE | 385,178 | 0 | 0 | ||
| Tscan Therapeutics Inc | COM | 89854M101 | 445,824 | 454,876 | SH | SOLE | 454,876 | 0 | 0 | ||
| Tyra Biosciences Inc | COM | 90240B106 | 2,378,412 | 74,465 | SH | SOLE | 74,465 | 0 | 0 | ||
| Uniqure Nv | SHS | N90064101 | 3,657,486 | 79,407 | SH | SOLE | 79,407 | 0 | 0 | ||
| Veradermics Inc | COOMON STOCK | 922967104 | 17,911,743 | 145,695 | SH | SOLE | 145,695 | 0 | 0 | ||
| X4 Pharmaceuticals Inc | COM NEW | 98420X202 | 17,385,663 | 3,722,840 | SH | SOLE | 3,722,840 | 0 | 0 | ||